In this webinar, Dr. Smoller describes the current status of psychiatric genetic research with a focus on depressive and anxiety disorders. Dr. Smoller reviews implications of this work for clinical practice, including the prospects and limitations of genetic or pharmacogenetic testing. He describes the potential for extending a precision medicine approach to the realm of depression and anxiety disorders.
At the end of this session, participants will be able to:
- Summarize progress in identifying the genetic basis of psychiatric disorders;
- Understand the implications of psychiatric genetics for clinical practice
- Discuss the current status of pharmacogenetic testing for psychiatric drug use.
This webinar is sponsored by the Genetics and Neuroscience Special Interest Group.